BEAM - CIK 0001745999
The table below shows Beam Therapeutics Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $294.94M | $281.97M | $435.89M | $232.77M | $559.99M | $162.17M |
| Short-term investments | $950.27M | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.27B |
| $878.15M |
| $1.21B |
| $1.09B |
| $1.27B |
| $308.32M |
| Property, plant & equipment | $104.50M | $111.41M | $124.96M | $115.62M | $84.26M | $38.51M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.48B | $1.10B | $1.46B | $1.34B | $1.47B | $451.68M |
| Accounts payable | $10.23M | $3.87M | $1.62M | $9.03M | $7.47M | $6.31M |
| Total current liabilities | $96.94M | $182.07M | $205.56M | $223.59M | $213.44M | $102.34M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $242.82M | $370.28M | $478.38M | $608.24M | $647.72M | $206.12M |
| Retained earnings | -$1.64B | -$1.57B | -$1.19B | -$1.06B | -$768.27M | -$397.64M |
| Total equity | $1.24B | $733.54M | $981.33M | $733.47M | $826.74M | $245.56M |